webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

DBCO-PEG4-DBCO

  CAS No.: 2182601-68-7   Cat No.: BADC-01077   Purity: >98.0% 4.5  

DBCO-PEG4-DBCO is a dual-functional ADC linker with two DBCO moieties, designed for bioorthogonal SPAAC reactions. Its PEG4 spacer enhances solubility and flexibility, making it suitable for antibody or payload crosslinking in ADC synthesis and other targeted drug delivery platforms.

DBCO-PEG4-DBCO

Structure of 2182601-68-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C48H50N4O8
Molecular Weight
810.93
Shipping
Room temperature
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
N-[3-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl]-3-[2-[2-[2-[3-[[3-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl]amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanamide; N,N'-bis(3-{2-azatricyclo[10.4.0.0,hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl}-3-oxopropyl)-4,7,10,13-tetraoxahexadecanediamide
IUPAC Name
N-[3-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl]-3-[2-[2-[2-[3-[[3-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl]amino]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanamide
Canonical SMILES
C1C2=CC=CC=C2C#CC3=CC=CC=C3N1C(=O)CCNC(=O)CCOCCOCCOCCOCCC(=O)NCCC(=O)N4CC5=CC=CC=C5C#CC6=CC=CC=C64
InChI
InChI=1S/C48H50N4O8/c53-45(49-25-21-47(55)51-35-41-13-3-1-9-37(41)17-19-39-11-5-7-15-43(39)51)23-27-57-29-31-59-33-34-60-32-30-58-28-24-46(54)50-26-22-48(56)52-36-42-14-4-2-10-38(42)18-20-40-12-6-8-16-44(40)52/h1-16H,21-36H2,(H,49,53)(H,50,54)
InChIKey
YCDMQCKYINAWGI-UHFFFAOYSA-N
Solubility
10 mm in DMSO
Appearance
Solid
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.
Form
Solid

DBCO-PEG4-DBCO, a versatile bifunctional linker, plays a prominent role in bioconjugation chemistry and molecular biology applications. Here are four key applications of DBCO-PEG4-DBCO:

Click Chemistry: Integral to copper-free click chemistry, DBCO-PEG4-DBCO is vital for the strain-promoted azide-alkyne cycloaddition (SPAAC) reaction. This enables precise and efficient conjugation of biomolecules under gentle conditions, making it perfect for labeling sensitive proteins, nucleic acids, and living cells. Consequently, this technique holds significant value for investigating intricate biological systems with minimal interference.

Drug Delivery Systems: The unique bifunctionality of DBCO-PEG4-DBCO positions it as an exceptional linker for constructing drug delivery systems. It facilitates the attachment of therapeutic agents to targeting moieties like antibodies or peptides, ensuring precise delivery to specific cells or tissues. This enhances therapeutic efficacy and diminishes side effects, aligning with the crucial objective of precision medicine.

Polymer and Nanomaterial Functionalization: In the realm of biomaterial modification, DBCO-PEG4-DBCO plays a pivotal role in introducing functional groups or creating biocompatible surfaces on polymers and nanomaterials. By appending bioactive molecules, these materials can be customized for various applications in biosensing, tissue engineering, and diagnostic assays. The linker’s capacity to enable robust and enduring bonding is paramount for the advancement of sophisticated biomaterial innovations.

In Vivo Imaging: Within the domain of in vivo imaging, DBCO-PEG4-DBCO is harnessed for generating fluorescent or radioactive probes that facilitate real-time tracking of biological processes. Through the linkage of imaging agents to specific biomolecules, researchers can visualize and monitor disease progression, cellular interactions, and treatment effects within living organisms. This non-invasive approach aids in comprehensively studying physiological and pathological phenomena in an organismic context.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Mal-Phe-C4-Val-Cit-PAB | Methotrexate-d3 | tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate | Biotin-sar-oh | DBCO-Peg4-VC-PAB-MMAE | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate | DBCO-PEG4-DBCO | DBCO-PEG2-NHS ester
Send Inquiry
Verification code
Inquiry Basket